Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Moderna, Inc. (MRNA) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Moderna, Inc. (MRNA) - free report >>
Image: Bigstock
Top Ranked Momentum Stocks to Buy for November 8th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, November 8th:
CyberOptics Corporation : This high precision sensing technology developing company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
CyberOptics Corporation Price and Consensus
CyberOptics Corporation price-consensus-chart | CyberOptics Corporation Quote
CyberOptics’ shares gained nearly 30% over the last one month above the S&P 500’s increase 6.6%. The company possesses a Momentum Score of A.
CyberOptics Corporation Price
CyberOptics Corporation price | CyberOptics Corporation Quote
EverQuote, Inc. (EVER - Free Report) : This online marketplace for insurance shopping has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 37% over the last 60 days.
EverQuote, Inc. Price and Consensus
EverQuote, Inc. price-consensus-chart | EverQuote, Inc. Quote
EverQuote’s shares gained 52.8% over the last one month. The company possesses a Momentum Score of A.
EverQuote, Inc. Price
EverQuote, Inc. price | EverQuote, Inc. Quote
InMode Ltd. (INMD - Free Report) : This minimally-invasive aesthetic medical products development company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 12.3% over the last 60 days.
InMode Ltd. Price and Consensus
InMode Ltd. price-consensus-chart | InMode Ltd. Quote
InMode’s shares gained 80.9% over the last one month. The company possesses a Momentum Score of A.
InMode Ltd. Price
InMode Ltd. price | InMode Ltd. Quote
Moderna, Inc. (MRNA - Free Report) : This clinical stage biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.9% over the last 60 days.
Moderna, Inc. Price and Consensus
Moderna, Inc. price-consensus-chart | Moderna, Inc. Quote
Moderna’s shares gained 14.3% over the last one month. The company possesses a Momentum Score of A.
Moderna, Inc. Price
Moderna, Inc. price | Moderna, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.
This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.
See their latest picks free >>